• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    4/3/23 1:36:59 PM ET
    $ADV
    $AGLE
    $ALLR
    $ALRN
    Real Estate
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADV alert in real time by email

     

    On Monday, 76 companies set new 52-week lows.

    Facts of Interest About Today's 52-Week Lows:

    • CVB Financial (NASDAQ:CVBF) was the biggest company in terms of market cap to set a new 52-week low.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) was the smallest firm by market cap to set a new 52-week low.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX)'s stock moved significantly downwards, trading down 25.64% to reach a new 52-week low.
    • Aeglea BioTherapeutics (NASDAQ:AGLE) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low.

    Here is a list of stocks that set new 52-week lows on Monday:

    • CVB Financial (NASDAQ:CVBF) shares made a new 52-week low of $16.33 on Monday. The stock was down 1.78% for the day.
    • Semtech (NASDAQ:SMTC) stock drifted down 4.73% on Monday morning to hit a new 52-week low of $22.83.
    • Westamerica Bancorp (NASDAQ:WABC) shares fell to $43.21 on Monday, setting a new 52-week low with a shift of down 2.13%.
    • Canopy Gwth (NASDAQ:CGC) stock set a new 52-week low of $1.70 on Monday, moving down 2.57%.
    • Twist Bioscience (NASDAQ:TWST) shares moved down 7.69% on Monday to hit a new 52-week low of $13.89, drifting down 7.69%.
    • Advantage Solutions (NASDAQ:ADV) stock achieved a new 52-week low on Monday morning, hitting $1.54 and moving up 7.59%.
    • Northfield Bancorp (NASDAQ:NFBK) stock broke to a new 52-week low of $11.59 on Monday. Shares of the company traded down 0.93%.
    • Sharecare (NASDAQ:SHCR) shares set a new yearly low of $1.32 this morning. The stock was down 5.99% on the session.
    • Southern Missouri Bancorp (NASDAQ:SMBC) stock dropped to a yearly low on Monday of $36.86. Shares traded down 1.06%.
    • First Community (NASDAQ:FCBC) shares were down 0.02% for the day, having made a 52-week low of $24.73.
    • Bank of Marin (NASDAQ:BMRC) shares made a new 52-week low of $21.30 on Monday. The stock was down 2.38% for the day.
    • Guaranty Bancshares (NYSE:GNTY) stock hit $26.56 on Monday morning, setting a new 52-week low for a change of down 4.02%.
    • Nano X Imaging (NASDAQ:NNOX) stock dropped to a yearly low on Monday of $5.49. Shares traded down 4.51%.
    • Summit Finl Gr (NASDAQ:SMMF) stock drifted down 1.06% on Monday morning to hit a new 52-week low of $20.34.
    • Sierra (NASDAQ:BSRR) stock drifted down 1.8% on Monday morning to hit a new 52-week low of $16.87.
    • MVB Financial (NASDAQ:MVBF) stock set a new 52-week low of $19.86 on Monday, moving down 2.37%.
    • Southern First Bancshares (NASDAQ:SFST) shares made a new 52-week low of $29.87 on Monday. The stock was down 1.99% for the day.
    • Kezar Life Sciences (NASDAQ:KZR) stock dropped to a yearly low on Monday of $3.08. Shares traded down 0.96%.
    • BayCom (NASDAQ:BCML) shares were down 2.69% for the day, having made a 52-week low of $16.59.
    • Inovio Pharmaceuticals (NASDAQ:INO) shares set a new 52-week low of $0.77. The stock traded down 5.09%.
    • Satellogic (NASDAQ:SATL) shares fell to $2.10 on Monday, setting a new 52-week low with a shift of down 0.47%.
    • ALX Oncology Holdings (NASDAQ:ALXO) stock set a new 52-week low of $4.43 on Monday, moving down 0.22%.
    • First Guaranty Bancshares (NASDAQ:FGBI) stock hit $14.08 on Monday morning, setting a new 52-week low for a change of down 7.34%.
    • Wheels Up Experience (NYSE:UP) stock hit a new 52-week low of $0.58. The stock was down 5.18% on the session.
    • First Internet (NASDAQ:INBK) stock achieved a new 52-week low on Monday morning, hitting $16.10 and moving down 3.3%.
    • FLJ Group (NASDAQ:FLJ) stock set a new 52-week low of $0.70 on Monday, moving down 3.56%.
    • YS Biopharma Co (NASDAQ:YS) shares moved down 10.63% on Monday to hit a new 52-week low of $1.40, drifting down 10.63%.
    • Veru (NASDAQ:VERU) stock achieved a new 52-week low on Monday morning, hitting $1.13 and moving down 1.72%.
    • Vinco Ventures (NASDAQ:BBIG) stock dropped to a yearly low on Monday of $0.30. Shares traded down 5.51%.
    • Movella Holdings (NASDAQ:MVLA) stock drifted down 6.62% on Monday morning to hit a new 52-week low of $1.26.
    • Snail (NASDAQ:SNAL) shares hit a yearly low of $1.24. The stock was down 3.28% on the session.
    • Bed Bath & Beyond (NASDAQ:BBBY) stock dropped to a yearly low on Monday of $0.37. Shares traded down 10.32%.
    • Hongli Group (NASDAQ:HLP) shares reached a new 52-week low of $3.25 on Monday morning, moving up 1.44%.
    • Rubicon Technologies (NYSE:RBT) shares hit a yearly low of $0.50. The stock was down 17.08% on the session.
    • Foresight Autonomous (NASDAQ:FRSX) stock hit a yearly low of $0.40. The stock was down 0.73% for the day.
    • Appreciate Holdings (NASDAQ:SFR) shares were down 5.7% for the day, having made a 52-week low of $0.51.
    • Chanson International (NASDAQ:CHSN) shares were down 15.17% for the day, having made a 52-week low of $1.69.
    • Unity Biotechnology (NASDAQ:UBX) stock hit a yearly low of $1.54. The stock was down 3.67% for the day.
    • Beamr Imaging (NASDAQ:BMR) shares moved down 13.07% on Monday to hit a new 52-week low of $1.71, drifting down 13.07%.
    • SMX (Security Matters) (NASDAQ:SMX) shares fell to $0.85 on Monday, setting a new 52-week low with a shift of down 6.38%.
    • ICZOOM Group (NASDAQ:IZM) stock achieved a new 52-week low on Monday morning, hitting $1.69 and moving up 6.94%.
    • Aeglea BioTherapeutics (NASDAQ:AGLE) shares reached a new 52-week low of $0.28 on Monday morning, moving 0.0% (flat).
    • Trinity Place Hldgs (AMEX:TPHS) shares set a new 52-week low of $0.44. The stock traded down 4.17%.
    • Micromobility com (NASDAQ:MCOM) stock broke to a new 52-week low of $2.72 on Monday. Shares of the company traded down 24.86%.
    • Aprea Therapeutics (NASDAQ:APRE) shares made a new 52-week low of $4.28 on Monday. The stock was down 3.6% for the day.
    • Microbot Medical (NASDAQ:MBOT) stock drifted down 5.03% on Monday morning to hit a new 52-week low of $1.91.
    • Asset Entities (NASDAQ:ASST) shares set a new 52-week low of $1.09. The stock traded down 13.85%.
    • Generation Income (NASDAQ:GIPR) shares fell to $4.47 on Monday, setting a new 52-week low with a shift of up 3.78%.
    • Coffee Holding Co (NASDAQ:JVA) shares set a new yearly low of $1.73 this morning. The stock was down 4.36% on the session.
    • Aridis Pharmaceuticals (NASDAQ:ARDS) stock set a new 52-week low of $0.15 on Monday, moving down 17.86%.
    • Imunon (NASDAQ:IMNN) shares moved down 0.49% on Monday to hit a new 52-week low of $1.21, drifting down 0.49%.
    • Cyclo Therapeutics (NASDAQ:CYTH) stock achieved a new 52-week low on Monday morning, hitting $0.80 and moving up 1.18%.
    • Auddia (NASDAQ:AUUD) shares moved down 5.35% on Monday to hit a new 52-week low of $0.67, drifting down 5.35%.
    • Redhill Biopharma (NASDAQ:RDHL) stock broke to a new 52-week low of $3.71 on Monday. Shares of the company traded down 7.58%.
    • Diffusion Pharmaceuticals (NASDAQ:DFFN) shares reached a new 52-week low of $3.80 on Monday morning, moving down 1.22%.
    • XORTX Therapeutics (NASDAQ:XRTX) shares set a new yearly low of $0.42 this morning. The stock was down 3.25% on the session.
    • Ensysce Biosciences (NASDAQ:ENSC) shares moved down 7.61% on Monday to hit a new 52-week low of $4.45, drifting down 7.61%.
    • Aileron Therapeutics (NASDAQ:ALRN) stock set a new 52-week low of $1.21 on Monday, moving down 2.42%.
    • Codiak BioSciences (NASDAQ:CDAK) stock dropped to a yearly low on Monday of $0.13. Shares traded down 14.67%.
    • Cryptyde (NASDAQ:TYDE) shares reached a new 52-week low of $0.07 on Monday morning, moving down 9.98%.
    • SINTX Technologies (NASDAQ:SINT) stock hit $1.84 on Monday morning, setting a new 52-week low for a change of down 8.78%.
    • Minim (NASDAQ:MINM) stock hit $0.08 on Monday morning, setting a new 52-week low for a change of down 20.75%.
    • Tenax Therapeutics (NASDAQ:TENX) shares reached a new 52-week low of $0.41 on Monday morning, moving down 9.68%.
    • Fresh Tracks Therapeutics (NASDAQ:FRTX) stock achieved a new 52-week low on Monday morning, hitting $0.64 and moving down 1.26%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares set a new yearly low of $1.63 this morning. The stock was up 18.27% on the session.
    • G Medical Innovations (NASDAQ:GMVD) shares hit a yearly low of $0.71. The stock was down 19.78% on the session.
    • CNS Pharmaceuticals (NASDAQ:CNSP) shares fell to $0.92 on Monday, setting a new 52-week low with a shift of 0.0% (flat).
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares were down 25.64% for the day, having made a 52-week low of $0.29.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ADV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADV
    $AGLE
    $ALLR
    $ALRN

    CompanyDatePrice TargetRatingAnalyst
    First Internet Bancorp
    $INBK
    1/30/2026$26.00 → $29.00Outperform
    Hovde Group
    Satellogic Inc.
    $SATL
    1/21/2026$5.00Buy
    Craig Hallum
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    Microbot Medical Inc.
    $MBOT
    12/3/2025$5.50Buy
    Roth Capital
    Semtech Corporation
    $SMTC
    11/25/2025Hold → Buy
    Summit Insights
    ALX Oncology Holdings Inc.
    $ALXO
    11/13/2025$4.00Buy
    Jefferies
    Canopy Growth Corporation
    $CGC
    11/10/2025Sell → Hold
    The Benchmark Company
    Twist Bioscience Corporation
    $TWST
    11/4/2025$41.00Overweight
    Stephens
    More analyst ratings

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wheels Up Announces Fernando Mendoza as Brand Ambassador

    Heisman Trophy-Winning and NCAA National Champion Quarterback Joins the Wheels Up Community ATLANTA, Feb. 5, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP), one of the world's leading providers of on-demand private aviation, today announced that NCAA National Champion and 2025 Heisman Trophy winner Fernando Mendoza is a new addition to the Wheels Up Ambassador community. Recognized as the most accomplished collegiate football player this season, Mendoza represents the next generation of elite athletes whose lives and careers demand flexibility, efficiency, and connectivity across every mode of travel.

    2/5/26 8:30:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

    HINGHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it is attending the Society of Interventional Oncology (SIO) annual meeting, being held in Savannah, GA, February 4-8, 2026. The timing of the conference, which is during the Company's limited market release of the LIBERTY System, will allow the Company to share practical insights and personal experiences from physicians who have used LIBERTY across hospitals and procedure types. This conference also marks the first commercial exhibition of LIBERTY following the commencement of the limited market release in l

    2/5/26 8:30:00 AM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY

    Strategic Restructuring Eliminates Expenses Not Essential to the Phase 3 Study Khursheed Anwer, Ph.D., Executive Vice President and Chief Scientific Officer, will retire after nearly 12 years at the company Phase 3 Study enrollment remains ahead of schedule and advances the company toward future BLA filing LAWRENCEVILLE, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced a strategic reorganization that will eliminate headcount not essential to the Phase 3 trial and redefine the job descriptions for additional employees to reduce operating expenses while supporting the co

    2/5/26 8:05:00 AM ET
    $IMNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADV
    $AGLE
    $ALLR
    $ALRN
    SEC Filings

    View All

    Twist Bioscience Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Twist Bioscience Corp (0001581280) (Filer)

    2/6/26 5:25:52 PM ET
    $TWST
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 10-Q filed by Southern Missouri Bancorp Inc.

    10-Q - SOUTHERN MISSOURI BANCORP, INC. (0000916907) (Filer)

    2/6/26 4:52:07 PM ET
    $SMBC
    Banks
    Finance

    SEC Form S-3 filed by Southern First Bancshares Inc.

    S-3 - SOUTHERN FIRST BANCSHARES INC (0001090009) (Filer)

    2/6/26 4:39:41 PM ET
    $SFST
    Major Banks
    Finance

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Goodman Corey S bought $4,999,999 worth of shares (3,184,713 units at $1.57) (SEC Form 4)

    4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    2/4/26 4:15:59 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President/CEO Gilad Oren bought $25,009 worth of shares (28,100 units at $0.89), increasing direct ownership by 8% to 373,720 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:08:08 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. bought $5,073 worth of shares (5,700 units at $0.89), increasing direct ownership by 21% to 33,433 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:05:34 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hovde Group reiterated coverage on First Internet Bancorp with a new price target

    Hovde Group reiterated coverage of First Internet Bancorp with a rating of Outperform and set a new price target of $29.00 from $26.00 previously

    1/30/26 6:48:44 AM ET
    $INBK
    Major Banks
    Finance

    Craig Hallum initiated coverage on Satellogic with a new price target

    Craig Hallum initiated coverage of Satellogic with a rating of Buy and set a new price target of $5.00

    1/21/26 8:14:53 AM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Canaccord Genuity initiated coverage on Veru with a new price target

    Canaccord Genuity initiated coverage of Veru with a rating of Buy and set a new price target of $25.00

    12/18/25 9:11:57 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADV
    $AGLE
    $ALLR
    $ALRN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    March 26, 2021 - Coronavirus (COVID-19) Update: March 26, 2021

    For Immediate Release: March 26, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On March 23, 2021, the FDA issued an emergency use authorization (EUA) to the Twist Bioscience Corporation for their SARS-CoV-2 NGS Assay. The SARS-CoV-2 NGS Assay is a next-generation sequencing (NGS) based test for the identification of SARS-CoV-2 RNA from respirato

    3/26/21 3:51:09 PM ET
    $TWST
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Director Stahlin Paul

    4/A - Northfield Bancorp, Inc. (0001493225) (Issuer)

    2/6/26 6:13:31 PM ET
    $NFBK
    Savings Institutions
    Finance

    Amendment: SEC Form 4 filed by Director Catino Annette

    4/A - Northfield Bancorp, Inc. (0001493225) (Issuer)

    2/6/26 6:13:25 PM ET
    $NFBK
    Savings Institutions
    Finance

    Amendment: SEC Form 4 filed by Director Patafio Frank P.

    4/A - Northfield Bancorp, Inc. (0001493225) (Issuer)

    2/6/26 6:13:12 PM ET
    $NFBK
    Savings Institutions
    Finance

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Financials

    Live finance-specific insights

    View All

    Wheels Up Announces Date of Fourth Quarter 2025 Earnings Release

    ATLANTA, Feb. 5, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) today announced that it will release its fourth quarter 2025 financial results on Thursday, February 19, 2026. Earnings materials will be available on the Wheels Up investor relations website at investors.wheelsup.com. About Wheels Up Wheels Up is a leading global provider of on-demand private aviation with a large, diverse fleet and a network of safety-vetted charter operators, all committed to safety and service. Customers access charter and membership programs and premium commercial travel benefits th

    2/5/26 8:00:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th

    MIAMI, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Wednesday, February 11, 2026, at 8:00 a.m. ET to discuss its fiscal 2026 first quarter financial results and to provide a business update. The audio webcast will be accessible under the Home page and Investors page of the Company's website at www.verupharma.com. To join the conference call via telephone, please dial 1-800-341-1602 (domestic) or 1-412-902-6706 (international) and ask to join the Veru I

    2/4/26 8:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bed Bath & Beyond, Inc. Scheduled to Release Fourth Quarter & Full Year 2025 Financial Results

    Bed Bath & Beyond, Inc. (NYSE:BBBY) (the "Company"), owner of Bed Bath & Beyond, Overstock, buybuy BABY, and a blockchain asset portfolio, today announced that it is scheduled to release fourth quarter & full year 2025 financial results after the market closes on Monday, February 23, 2026. The Company has also scheduled a conference call and webcast to be held on Monday, February 23, 2026, at 4:30pm ET to discuss these results and take questions from participants during the live event. Questions may also be submitted to [email protected] in advance. Webcast and Replay Information To access the live webcast, visit investors.beyond.com. To participate in the conference call via telephone, p

    2/2/26 8:30:00 AM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Hongli Group Inc.

    SC 13G - Hongli Group Inc. (0001855557) (Subject)

    12/12/24 6:49:27 PM ET
    $HLP
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Hongli Group Inc.

    SC 13G - Hongli Group Inc. (0001855557) (Subject)

    12/12/24 6:47:57 PM ET
    $HLP
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Hongli Group Inc.

    SC 13G - Hongli Group Inc. (0001855557) (Subject)

    12/12/24 6:45:55 PM ET
    $HLP
    Industrial Machinery/Components
    Industrials

    $ADV
    $AGLE
    $ALLR
    $ALRN
    Leadership Updates

    Live Leadership Updates

    View All

    XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

    CALGARY, Alberta, Feb. 04, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that further to its press release of October 17, 2025 and an update on December 31, 2025, the Company has entered into an extension agreement with Vectus Biosystems Limited ("Vectus") to allow further time to complete the acquisition of the Renal Anti-Fibrotic Therapeutic Program from Vectus (the "Acquisition"). The term sheet entered into October 17th (the "Term Sheet") to acquire the novel new chemical

    2/4/26 6:00:00 PM ET
    $XRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor

    DOYLESTOWN, Pa., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies that exploit cancer-specific vulnerabilities while minimizing damage to healthy cells, today announced the appointment of Eugene (Gene) Kennedy, MD, as Chief Medical Advisor. Dr. Kennedy joins Aprea at an important time, following the Company's recent early clinical proof-of-concept demonstrated in its ongoing Phase 1 dose-escalation study evaluating the WEE1 inhibitor APR-1051 in patients with advanced solid tumors. He is a highly accomplished physician scientist and biopharmaceutical executive wit

    2/4/26 8:30:00 AM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Strive Announces the Completion of Semler Scientific Acquisition

    DALLAS, TX, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST) ("Strive") today announced the successful completion of the previously announced acquisition of Semler Scientific. Strive now holds approximately 12,797.9 bitcoin, becoming the #11 largest public corporate holder of bitcoin globally. Strive also announces the appointment of Avik Roy as Chief Strategy Officer of Strive. Mr. Roy's initial focus will be on Strive's intentions to monetize the operating business from the Semler Scientific subsidiary by expanding its mandate in early disease detection products.  Mr. Roy began his career in science at MIT and trained as a physician at Yale Medical School before joining Ba

    1/16/26 8:40:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care